Johannes Laengle

722 total citations
25 papers, 505 citations indexed

About

Johannes Laengle is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Johannes Laengle has authored 25 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Johannes Laengle's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Johannes Laengle is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Johannes Laengle collaborates with scholars based in Austria, United Kingdom and Russia. Johannes Laengle's co-authors include Michael Bergmann, Monika Sachet, Branka Petričević, Josef Singer, Rupert Bartsch, Erika Jensen‐Jarolim, Guenther G. Steger, Judit Fazekas, Anne Miller and Arvand Haschemi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cell Metabolism.

In The Last Decade

Johannes Laengle

24 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Laengle Austria 12 227 183 181 90 61 25 505
Rancés Blanco Cuba 15 237 1.0× 206 1.1× 303 1.7× 115 1.3× 59 1.0× 45 607
Boris Brill Germany 15 183 0.8× 177 1.0× 266 1.5× 50 0.6× 61 1.0× 33 578
D. Carbone United States 9 231 1.0× 261 1.4× 230 1.3× 53 0.6× 34 0.6× 15 530
Karine Bernardeau France 14 96 0.4× 246 1.3× 95 0.5× 73 0.8× 31 0.5× 19 457
Joana Carvalho United Kingdom 11 207 0.9× 121 0.7× 356 2.0× 28 0.3× 105 1.7× 13 552
Sherly Mosessian United States 8 144 0.6× 75 0.4× 423 2.3× 38 0.4× 59 1.0× 12 627
Ursula R. Sorg Germany 13 177 0.8× 186 1.0× 254 1.4× 22 0.2× 33 0.5× 26 580
Cinzia Remondo Italy 12 517 2.3× 479 2.6× 216 1.2× 53 0.6× 65 1.1× 16 795
Olga Blomberg Netherlands 9 293 1.3× 303 1.7× 181 1.0× 140 1.6× 33 0.5× 9 583
Zohar Mishal France 16 104 0.5× 287 1.6× 209 1.2× 54 0.6× 66 1.1× 28 677

Countries citing papers authored by Johannes Laengle

Since Specialization
Citations

This map shows the geographic impact of Johannes Laengle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Laengle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Laengle more than expected).

Fields of papers citing papers by Johannes Laengle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Laengle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Laengle. The network helps show where Johannes Laengle may publish in the future.

Co-authorship network of co-authors of Johannes Laengle

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Laengle. A scholar is included among the top collaborators of Johannes Laengle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Laengle. Johannes Laengle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonas, Jan Philipp, David Pereyra, Jonas Santol, et al.. (2025). Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failure. HepatoBiliary Surgery and Nutrition. 14(1). 49–65. 1 indexed citations
2.
Hametner, Simon, Jutta Bergler‐Klein, Irene Kuehrer, et al.. (2025). Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial. MedComm. 6(7). e70275–e70275. 1 indexed citations
3.
Pandey, Ram Vinay, Lisa Kleißl, Johannes Laengle, et al.. (2024). Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer. Nature Communications. 15(1). 6949–6949. 13 indexed citations
4.
Laengle, Johannes, et al.. (2023). Liver surgery in the 2020s: ante-situm and in-situ resection are still indicated – A single-center study. HPB. 25(9). 1030–1039. 3 indexed citations
5.
Santol, Jonas, David Pereyra, Johannes Laengle, et al.. (2023). Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration. Scientific Reports. 13(1). 15980–15980. 4 indexed citations
6.
7.
8.
Laengle, Johannes, Irene Kuehrer, Dietmar Pils, et al.. (2021). Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.. Journal of Clinical Oncology. 39(15_suppl). TPS3623–TPS3623. 3 indexed citations
9.
Müller, Catharina, Johannes Laengle, Stefan Riss, Michael Bergmann, & Thomas Bachleitner‐Hofmann. (2021). Surgical Complexity and Outcome During the Implementation Phase of a Robotic Colorectal Surgery Program—A Retrospective Cohort Study. Frontiers in Oncology. 10. 603216–603216. 8 indexed citations
10.
Laengle, Johannes, et al.. (2020). Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis. Journal for ImmunoTherapy of Cancer. 8(1). e000195–e000195. 34 indexed citations
11.
12.
Stremitzer, Stefan, Judith Stift, Johannes Laengle, et al.. (2020). Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma. Annals of Surgical Oncology. 28(3). 1493–1498. 10 indexed citations
13.
Laengle, Johannes, et al.. (2019). Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis. European Journal of Cancer. 110. S5–S5. 3 indexed citations
14.
Laengle, Johannes, Judith Stift, Brigitte Wolf, et al.. (2018). DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells. Theranostics. 8(12). 3198–3213. 23 indexed citations
15.
Miller, Anne, Bernhard Knapp, Johannes Laengle, et al.. (2017). Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments. Cell Metabolism. 26(5). 788–800.e6. 87 indexed citations
16.
Klymiuk, Ingeborg, Martina Schneider, Susanne Fister, et al.. (2017). Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. The FASEB Journal. 31(5). 1987–2000. 31 indexed citations
17.
Kosulin, Karin, Johannes Laengle, Rodrig Marculescu, et al.. (2016). Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cells. The Journal of Steroid Biochemistry and Molecular Biology. 165(Pt B). 356–362. 18 indexed citations
18.
Hock, Karin, Johannes Laengle, И. Л. Кузнецова, et al.. (2016). Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo. Surgery. 161(3). 735–746. 33 indexed citations
19.
Weiss, René, Johannes Laengle, Monika Sachet, et al.. (2015). Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis. Antiviral Research. 123. 93–104. 17 indexed citations
20.
Petričević, Branka, Johannes Laengle, Josef Singer, et al.. (2013). Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients. Journal of Translational Medicine. 11(1). 307–307. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rancés Blanco Breakdown of academic impact, for papers by Boris Brill Breakdown of academic impact, for papers by D. Carbone Breakdown of academic impact, for papers by Karine Bernardeau Breakdown of academic impact, for papers by Joana Carvalho Breakdown of academic impact, for papers by Sherly Mosessian Breakdown of academic impact, for papers by Ursula R. Sorg Breakdown of academic impact, for papers by Cinzia Remondo Breakdown of academic impact, for papers by Olga Blomberg Breakdown of academic impact, for papers by Zohar Mishal
Rankless by CCL
2026